Apollomics (APLM) Preferred Stock Liabilities (2021 - 2023)

Apollomics (APLM) posted quarterly Preferred Stock Liabilities of -$76.4 million for Q4 2023, up 59.7% year-on-year from -$47.9 million in Q4 2022, and little changed on a QoQ basis from -$76.4 million in Q2 2023.

Apollomics (APLM) Preferred Stock Liabilities (2021 - 2023) Analysis & Trends

Apollomics (APLM) has reported Preferred Stock Liabilities for 3 consecutive years, with -$76.4 million the latest figure, recorded in Q4 2023.

  • Quarterly Preferred Stock Liabilities rose 59.7% year-over-year to -$76.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$76.4 million (up 59.7% YoY) and the FY2023 annual result came in at -$76.4 million, down 114.93% from the prior year.
  • Preferred Stock Liabilities was little changed at -$76.4 million in Q4 2023 per APLM's latest filing, from -$76.4 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for APLM reached as high as $23.7 million in Q2 2022 and fell as low as -$189.6 million in Q4 2022.
  • A 3-year average of -$71.3 million and a median of -$76.4 million in 2023 frame the typical range for Preferred Stock Liabilities.
  • The largest YoY upside for Preferred Stock Liabilities was 59.7% in 2023 against a maximum downside of 422.91% in 2023.
  • Year by year, Preferred Stock Liabilities stood at -$37.4 million in 2021, then sank by 406.75% to -$189.6 million in 2022, then surged by 59.7% to -$76.4 million in 2023.
  • According to Business Quant data, Preferred Stock Liabilities over the past three periods registered -$76.4 million, -$76.4 million, and -$189.6 million for Q4 2023, Q2 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Apollomics 2.66 Bn 2.66 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -76.43 Mn
Jun 30, 2023 -76.43 Mn
Dec 31, 2022 -189.65 Mn
Jun 30, 2022 23.67 Mn
Dec 31, 2021 -37.42 Mn